CN1417347A - 分类学鉴定病源微生物及其毒性蛋白 - Google Patents
分类学鉴定病源微生物及其毒性蛋白 Download PDFInfo
- Publication number
- CN1417347A CN1417347A CN02143520A CN02143520A CN1417347A CN 1417347 A CN1417347 A CN 1417347A CN 02143520 A CN02143520 A CN 02143520A CN 02143520 A CN02143520 A CN 02143520A CN 1417347 A CN1417347 A CN 1417347A
- Authority
- CN
- China
- Prior art keywords
- analyte
- catching
- exposed
- detects
- direct bearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000052769 pathogen Species 0.000 title description 2
- 239000012491 analyte Substances 0.000 claims abstract description 127
- 238000000034 method Methods 0.000 claims abstract description 119
- 244000005700 microbiome Species 0.000 claims abstract description 81
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 27
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 239000000589 Siderophore Substances 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 238000004458 analytical method Methods 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 9
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- 239000003446 ligand Substances 0.000 claims abstract description 7
- -1 heme compounds Chemical class 0.000 claims abstract description 6
- 150000002632 lipids Chemical class 0.000 claims abstract description 6
- 238000000386 microscopy Methods 0.000 claims abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 4
- 101710116435 Outer membrane protein Proteins 0.000 claims abstract 5
- 241000894006 Bacteria Species 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 230000000813 microbial effect Effects 0.000 claims description 17
- 229910000077 silane Inorganic materials 0.000 claims description 11
- 125000000524 functional group Chemical group 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 230000010748 Photoabsorption Effects 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 238000007689 inspection Methods 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 239000007822 coupling agent Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 238000012512 characterization method Methods 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 125000000962 organic group Chemical group 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 229920000232 polyglycine polymer Polymers 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000985 reactive dye Substances 0.000 claims 24
- 238000000926 separation method Methods 0.000 claims 6
- 230000001086 cytosolic effect Effects 0.000 claims 4
- 238000010791 quenching Methods 0.000 claims 3
- 230000000171 quenching effect Effects 0.000 claims 3
- 239000006249 magnetic particle Substances 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 1
- 238000000504 luminescence detection Methods 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 108010094020 polyglycine Proteins 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000003287 optical effect Effects 0.000 abstract description 3
- 238000002835 absorbance Methods 0.000 abstract 1
- 238000004020 luminiscence type Methods 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 238000000059 patterning Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 20
- 238000005516 engineering process Methods 0.000 description 17
- 239000011521 glass Substances 0.000 description 15
- 239000003053 toxin Substances 0.000 description 14
- 231100000765 toxin Toxicity 0.000 description 14
- 108700012359 toxins Proteins 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 150000002482 oligosaccharides Chemical class 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229920001542 oligosaccharide Polymers 0.000 description 8
- NYBZAGXTZXPYND-GBIKHYSHSA-N pyochelin I Chemical compound S1C[C@@H](C(O)=O)N(C)[C@H]1[C@@H]1N=C(C=2C(=CC=CC=2)O)SC1 NYBZAGXTZXPYND-GBIKHYSHSA-N 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 6
- 239000006035 Tryptophane Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229960004799 tryptophan Drugs 0.000 description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
- OZZLZFXDNDCIOU-UHFFFAOYSA-N Alcalignin Natural products OC1CCN(O)C(=O)CCC(=O)NCC(O)CCN(O)C(=O)CCC(=O)NC1 OZZLZFXDNDCIOU-UHFFFAOYSA-N 0.000 description 5
- 108010061075 Enterobactin Proteins 0.000 description 5
- SERBHKJMVBATSJ-UHFFFAOYSA-N Enterobactin Natural products OC1=CC=CC(C(=O)NC2C(OCC(C(=O)OCC(C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-UHFFFAOYSA-N 0.000 description 5
- 241000590002 Helicobacter pylori Species 0.000 description 5
- OZZLZFXDNDCIOU-RYUDHWBXSA-N alcaligin Chemical compound O[C@H]1CCN(O)C(=O)CCC(=O)NC[C@@H](O)CCN(O)C(=O)CCC(=O)NC1 OZZLZFXDNDCIOU-RYUDHWBXSA-N 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- SERBHKJMVBATSJ-BZSNNMDCSA-N enterobactin Chemical compound OC1=CC=CC(C(=O)N[C@@H]2C(OC[C@@H](C(=O)OC[C@@H](C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-BZSNNMDCSA-N 0.000 description 5
- 229940037467 helicobacter pylori Drugs 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 101001023095 Anemonia sulcata Delta-actitoxin-Avd1a Proteins 0.000 description 4
- 101000641989 Araneus ventricosus Kunitz-type U1-aranetoxin-Av1a Proteins 0.000 description 4
- 241000193738 Bacillus anthracis Species 0.000 description 4
- 101001028691 Carybdea rastonii Toxin CrTX-A Proteins 0.000 description 4
- 101000685083 Centruroides infamatus Beta-toxin Cii1 Proteins 0.000 description 4
- 101000685085 Centruroides noxius Toxin Cn1 Proteins 0.000 description 4
- 101001028688 Chironex fleckeri Toxin CfTX-1 Proteins 0.000 description 4
- 206010008631 Cholera Diseases 0.000 description 4
- 101000644407 Cyriopagopus schmidti U6-theraphotoxin-Hs1a Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 101000679608 Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) Cysteine rich necrotrophic effector Tox1 Proteins 0.000 description 4
- NYBZAGXTZXPYND-UHFFFAOYSA-N Pyochelin I Natural products S1CC(C(O)=O)N(C)C1C1N=C(C=2C(=CC=CC=2)O)SC1 NYBZAGXTZXPYND-UHFFFAOYSA-N 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 4
- 101710182532 Toxin a Proteins 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 206010013023 diphtheria Diseases 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- KDHHWXGBNUCREU-HOTGVXAUSA-N Ferric-aerobactin Chemical compound CC(=O)N(O)CCCC[C@@H](C(O)=O)NC(=O)CC(O)(C(O)=O)CC(=O)N[C@H](C(O)=O)CCCCN(O)C(C)=O KDHHWXGBNUCREU-HOTGVXAUSA-N 0.000 description 3
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- 201000005702 Pertussis Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 244000145469 Vernonia anthelmintica Species 0.000 description 3
- 235000013018 Vernonia anthelmintica Nutrition 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 3
- 238000006557 surface reaction Methods 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 101710092462 Alpha-hemolysin Proteins 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241000193155 Clostridium botulinum Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 108010053187 Diphtheria Toxin Proteins 0.000 description 2
- 102000016607 Diphtheria Toxin Human genes 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 229910003849 O-Si Inorganic materials 0.000 description 2
- 229910003872 O—Si Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010040070 Septic Shock Diseases 0.000 description 2
- 108010079723 Shiga Toxin Proteins 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 206010044248 Toxic shock syndrome Diseases 0.000 description 2
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 2
- 241000607734 Yersinia <bacteria> Species 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 201000006824 bubonic plague Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- XZGYBQIQSLSHDH-COEJQBHMSA-N mycobactin Chemical class C1CCCN(O)C(=O)C1NC(=O)C(C)C(CC)OC(=O)C(CCCCN(O)C(=O)\C=C/CCCCCCCCCCCCCCC)NC(=O)C(N=1)COC=1C1=C(C)C=CC=C1O XZGYBQIQSLSHDH-COEJQBHMSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 108010054967 vibriocin Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 101710197219 Alpha-toxin Proteins 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 101000585552 Bacillus anthracis Protective antigen Proteins 0.000 description 1
- 101000597249 Bacillus cereus Phospholipase C Proteins 0.000 description 1
- 101000730491 Bacillus cereus Phospholipase C Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 108010021408 Clostridium perfringens iota toxin Proteins 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 101900068981 Clostridium tetani Tetanus toxin Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 101000886418 Drosophila melanogaster GATA-binding factor C Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 101710082714 Exotoxin A Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 201000000628 Gas Gangrene Diseases 0.000 description 1
- 208000005168 Intussusception Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 108700005090 Lethal Genes Proteins 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 206010027241 Meningitis haemophilus Diseases 0.000 description 1
- 229930183781 Mycobactin Natural products 0.000 description 1
- OVRNDRQMDRJTHS-KEWYIRBNSA-N N-acetyl-D-galactosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-KEWYIRBNSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 101710124951 Phospholipase C Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010035728 Pneumonia pneumococcal Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 108090000899 Serralysin Proteins 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 101900219797 Serratia marcescens Serralysin Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 101000794214 Staphylococcus aureus Toxic shock syndrome toxin-1 Proteins 0.000 description 1
- 108010011834 Streptolysins Proteins 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 108010055044 Tetanus Toxin Proteins 0.000 description 1
- 101710101607 Toxic shock syndrome toxin-1 Proteins 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002776 alpha toxin Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 229940015062 campylobacter jejuni Drugs 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- SRMBQCVUAVULDJ-UHFFFAOYSA-N ferrioxamine b Chemical compound [Fe+3].CC(=O)N([O-])CCCCCNC(=O)CCC(=O)N([O-])CCCCCNC(=O)CCC(=O)N([O-])CCCCCN SRMBQCVUAVULDJ-UHFFFAOYSA-N 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010008385 glycolipid receptor Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003312 immunocapture Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 239000002719 pyrimidine nucleotide Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000022218 streptococcal pneumonia Diseases 0.000 description 1
- 231100000617 superantigen Toxicity 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229940118376 tetanus toxin Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/999,159 | 2001-11-01 | ||
| US09/999,159 US6780602B2 (en) | 2001-11-01 | 2001-11-01 | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1417347A true CN1417347A (zh) | 2003-05-14 |
Family
ID=25545977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN02143520A Pending CN1417347A (zh) | 2001-11-01 | 2002-09-27 | 分类学鉴定病源微生物及其毒性蛋白 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US6780602B2 (enExample) |
| EP (1) | EP1308520A3 (enExample) |
| JP (5) | JP2003185668A (enExample) |
| CN (1) | CN1417347A (enExample) |
| CA (1) | CA2402588A1 (enExample) |
| HK (1) | HK1054054A1 (enExample) |
| SG (5) | SG145552A1 (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8748122B2 (en) | 2008-12-16 | 2014-06-10 | BIO MéRIEUX, INC. | Methods for the characterization of microorganisms on solid or semi-solid media |
| CN104697989A (zh) * | 2013-12-06 | 2015-06-10 | 中国科学院理化技术研究所 | 含Fe3+的复合黏土的制备及其变色法检测水体生物毒性的方法 |
| CN107121396A (zh) * | 2008-09-24 | 2017-09-01 | 曙光生命科学公司 | 用于检测分析物的方法 |
| CN110087530A (zh) * | 2016-12-07 | 2019-08-02 | 普罗根尼蒂公司 | 胃肠道检测方法、装置和系统 |
| CN114359897A (zh) * | 2020-10-13 | 2022-04-15 | 深圳赛威玛智能科技有限公司 | 病原微生物的智能识别方法、计算机设备及可读存储介质 |
| CN117225491A (zh) * | 2023-11-15 | 2023-12-15 | 拜奥智能科技(山东)有限公司 | 一种可减少氨残留的定氮仪防溅瓶 |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10138072A1 (de) * | 2001-08-03 | 2003-02-27 | Fraunhofer Ges Forschung | Verfahren und Vorrichtung zum Bestimmen von Proteinen auf einem Reaktionsträger |
| US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| CN100362021C (zh) * | 2003-06-06 | 2008-01-16 | 河南大学 | 山药多糖-铁复合物及其制备工艺 |
| CN1914332A (zh) * | 2003-12-15 | 2007-02-14 | 快速实验室微系统公司 | 用于鉴定微生物的电化学分析 |
| JP4686703B2 (ja) * | 2004-10-29 | 2011-05-25 | 国立大学法人 名古屋工業大学 | 細胞固定化材 |
| US20070141597A1 (en) * | 2005-10-25 | 2007-06-21 | Harmon H J | Biomimetic Biodetector of Toxins, Viruses, Bacteria, and Biological Factors |
| JP2008249534A (ja) * | 2007-03-30 | 2008-10-16 | Sanyo Chem Ind Ltd | 免疫測定用担体 |
| EP2197350A2 (en) * | 2007-09-11 | 2010-06-23 | Baxter International Inc. | Infusion therapy sensor system |
| RU2519650C2 (ru) * | 2008-10-31 | 2014-06-20 | Биомерьё, Инк. | Способы разделения, характеристики и(или) идентификации микроорганизмов с помощью масс-спектрометрии |
| BRPI0919861A2 (pt) * | 2008-10-31 | 2017-04-04 | Bio Merieux Inc | metodos para a separacao, caracterizacao e/ou identificacao de micro-organismos por espectroscopia raman |
| US8647835B2 (en) | 2008-10-31 | 2014-02-11 | BIO MéRIEUX, INC. | Methods for separation, characterization and/or identification of microorganisms using spectroscopy |
| JP2012507712A (ja) * | 2008-10-31 | 2012-03-29 | バイオメリュー・インコーポレイテッド | 分光法を使用した微生物の分離、キャラクタリゼーションおよび/または同定方法 |
| BRPI0920114B1 (pt) * | 2008-10-31 | 2021-08-17 | Biomerieux, Inc. | Métodos para o isolamento e a identificação de micro-organismos |
| WO2010062350A1 (en) * | 2008-10-31 | 2010-06-03 | Biomerieux, Inc. | Methods for detection, characterization and/or identification of microorganisms in a sealed container |
| MX2011004169A (es) * | 2008-10-31 | 2011-09-27 | Bio Merieux Inc | Metodos para la separacion y caracterizacion de microorganismos utilizando agentes identificadores. |
| US8666673B2 (en) | 2010-05-14 | 2014-03-04 | Biomerieux, Inc | Identification and/or characterization of a microbial agent using taxonomic hierarchical classification |
| CA2798982C (en) | 2010-05-14 | 2017-11-28 | Biomerieux, Inc. | Identification and/or characterization of a microbial agent using taxonomic hierarchical classification |
| EP2585610A4 (en) * | 2010-06-25 | 2013-10-23 | Purdue Research Foundation | pATHOGEN DETECTION |
| US9880159B2 (en) | 2014-10-01 | 2018-01-30 | Linda S. Powers | Cartridge-based detection system |
| WO2016162504A1 (en) * | 2015-04-09 | 2016-10-13 | Koninklijke Philips N.V. | Method and apparatus for estimating the quantity of microorganisms within a taxonomic unit in a sample |
| US9867250B1 (en) | 2015-04-20 | 2018-01-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | System having a configurable pico-second pulsed LED driver circuit and photomultiplier tube biasing and gating circuits for real-time, time-resolved transient recording of fluorescence |
| US20210072255A1 (en) | 2016-12-16 | 2021-03-11 | The Brigham And Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
| ES2914787T3 (es) | 2016-12-16 | 2022-06-16 | Brigham & Womens Hospital Inc | Método para matriz de sensores de corona de proteínas para la detección temprana de enfermedades |
| CN112740017B (zh) * | 2018-04-19 | 2024-12-13 | 曙光诊断学公司 | 靶标检测 |
| GB2595583A (en) | 2018-11-07 | 2021-12-01 | Seer Inc | Compositions, methods and systems for protein corona analysis and uses thereof |
| CN114206214A (zh) | 2019-03-26 | 2022-03-18 | 禧尔公司 | 用于生物流体的蛋白质冕分析的组合物、方法和系统及其用途 |
| JP7441303B2 (ja) | 2019-08-05 | 2024-02-29 | シアー, インコーポレイテッド | サンプル調製、データ生成、タンパク質コロナ分析のためのシステムおよび方法 |
| CN116529393A (zh) | 2020-08-25 | 2023-08-01 | 禧尔公司 | 用于测定蛋白质和核酸的组合物和方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5958790A (en) | 1984-12-20 | 1999-09-28 | Nycomed Imaging As | Solid phase transverse diffusion assay |
| US5089395A (en) | 1985-02-27 | 1992-02-18 | University Of Cincinnati | Viable microorganism detection by induced fluorescence |
| US4746604A (en) | 1985-05-24 | 1988-05-24 | Enzo Biochem, Inc. | Specific binding assays utilizing a viable cell as a label |
| US5415997A (en) | 1987-07-28 | 1995-05-16 | Biotechnology Australia Pty Limited | Method for detecting low levels of microorganisms |
| US4953561A (en) * | 1989-09-18 | 1990-09-04 | Cancer Diagnostics, Inc. | Urine testing module and method of collecting urine antigen |
| US5766933A (en) * | 1989-04-26 | 1998-06-16 | Diagnostic Products Corporation | Method and element for measuring analytes in biological fluids using immobilized binder--analyte labeled complex |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6017722A (en) | 1991-04-04 | 2000-01-25 | Board Of Regents, The University Of Texas System | Luminous bacteria and methods for the isolation, identification and quantitation of toxicants |
| CA2107899A1 (en) * | 1991-04-10 | 1992-10-11 | Gunars Edwin Valkirs | Novel conjugates and assays for simultaneous detection of multiple ligands |
| DK39592D0 (da) | 1992-03-25 | 1992-03-25 | Safefood Micro Systsm As | Method of detecting microorganisms |
| GB9212416D0 (en) | 1992-06-11 | 1992-07-22 | Medical Res Council | Reversible binding substances |
| DK0653066T3 (da) | 1992-07-31 | 1998-09-23 | Dade Behring Marburg Gmbh | Fotoaktiverbare kemiluminescerende matricer |
| US6001556A (en) | 1992-11-13 | 1999-12-14 | The Regents Of The University Of California | Polymeric assay film for direct colorimetric detection |
| US5576220A (en) * | 1993-02-19 | 1996-11-19 | Arris Pharmaceutical Corporation | Thin film HPMP matrix systems and methods for constructing and displaying ligands |
| US5415999A (en) | 1993-07-09 | 1995-05-16 | Biocircuits Corporation | Fluorescent lipid polymer-macromolecular ligand compositions as detection element in ligand assays |
| US5986076A (en) | 1994-05-11 | 1999-11-16 | Trustees Of Boston University | Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| AU2636995A (en) | 1994-05-18 | 1995-12-05 | Research And Development Institute, Inc. | Simple, rapid method for the detection, identification and enumeration of specific viable microorganisms |
| AUPN214095A0 (en) | 1995-04-03 | 1995-04-27 | Australian Water Technologies Pty Ltd | Method for detecting microorganisms using flow cytometry |
| US5731148A (en) | 1995-06-07 | 1998-03-24 | Gen-Probe Incorporated | Adduct protection assay |
| US6159689A (en) | 1995-11-10 | 2000-12-12 | Genera Technologies Limited | Methods of capture and assay procedures |
| US5741662A (en) | 1995-12-18 | 1998-04-21 | Quidel Corporation | Direct stain specific binding assays for microorganisms |
| GB9608540D0 (en) | 1996-04-25 | 1996-07-03 | Medical Res Council | Isolation of enzymes |
| WO1997044491A1 (en) | 1996-05-22 | 1997-11-27 | The Johns Hopkins University | Methods of detection utilizing modified bacteriophage |
| US5760406A (en) * | 1996-06-03 | 1998-06-02 | Powers; Linda | Method and apparatus for sensing the presence of microbes |
| US5965532A (en) * | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US5972715A (en) | 1996-12-23 | 1999-10-26 | Bayer Corporation | Use of thermochromic liquid crystals in reflectometry based diagnostic methods |
| US5888066A (en) * | 1997-01-28 | 1999-03-30 | Diro, Inc. | Converter assembly for threaded dental implants |
| FR2758884B1 (fr) * | 1997-01-30 | 1999-04-02 | Bio Merieux | Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu |
| US6087088A (en) | 1997-01-31 | 2000-07-11 | Bayer Corporation | Binding assays using more than one label for determining analyte in the presence of interfering factors |
| US5763158A (en) | 1997-02-06 | 1998-06-09 | The United States Of America As Represented By The Secretary Of The Army | Detection of multiple antigens or antibodies |
| US5888760A (en) | 1997-04-10 | 1999-03-30 | Dade Microscan Inc. | Universal test systems and methods of use thereof for identifying multiple families of microorganisms |
| BR9800655A (pt) * | 1997-04-21 | 1999-08-10 | Randox Lab Ltd | Dispositivo de estado sólido para efetuar ensaios com múltiplos analisados seu uso e e sistema para análise de múltiplos analisados |
| WO1998049557A1 (en) * | 1997-04-28 | 1998-11-05 | B-E Safe, Inc. | Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states |
| US6197568B1 (en) | 1997-07-29 | 2001-03-06 | The Regents Of The University Of Michigan | Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms |
| ATE245485T1 (de) | 1997-10-27 | 2003-08-15 | Idexx Lab Inc | Vorrichtung zur bestimmung von analyten in lösungen |
| US5976827A (en) | 1997-12-12 | 1999-11-02 | Akzo Nobel, N.V. | Sensor device for detecting microorganisms and method therefor |
| US5912115A (en) | 1997-12-12 | 1999-06-15 | Akzo Nobel, N.V. | Evacuated sensor device for detecting microorganisms in blood samples, and method thereof |
| US6214628B1 (en) | 1998-01-14 | 2001-04-10 | Joseph R. Lakowicz | Method of conducting an assay of a sample containing an analyte of interest |
| US5968766A (en) * | 1998-03-31 | 1999-10-19 | B.E. Safe | Method and apparatus for sensing the presence of microbes |
| AU4544099A (en) * | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Novel therapeutic agents for macromolecular structures |
| US6051388A (en) | 1998-12-22 | 2000-04-18 | Toxin Alert, Inc. | Method and apparatus for selective biological material detection |
| JP2002544486A (ja) * | 1999-05-10 | 2002-12-24 | プロリンクス・インコーポレイテッド | 細胞分離装置およびその使用法 |
| US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
| US6395504B1 (en) * | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
| US20020187464A1 (en) * | 2000-09-22 | 2002-12-12 | Klempner Mark S. | Microarray-based method for rapid identification of cells, microorganisms, or protein mixtures |
| CA2764288A1 (en) * | 2000-11-27 | 2002-05-30 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
| US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| US20060257929A1 (en) * | 2003-11-12 | 2006-11-16 | Microbiosystems, Limited Partnership | Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins |
-
2001
- 2001-11-01 US US09/999,159 patent/US6780602B2/en not_active Expired - Fee Related
-
2002
- 2002-09-10 CA CA002402588A patent/CA2402588A1/en not_active Abandoned
- 2002-09-27 SG SG200407092-6A patent/SG145552A1/en unknown
- 2002-09-27 SG SG200205915-2A patent/SG130937A1/en unknown
- 2002-09-27 EP EP02021593A patent/EP1308520A3/en not_active Ceased
- 2002-09-27 SG SG200407090-0A patent/SG152039A1/en unknown
- 2002-09-27 SG SG200406358-2A patent/SG152902A1/en unknown
- 2002-09-27 CN CN02143520A patent/CN1417347A/zh active Pending
- 2002-09-27 SG SG200407091-8A patent/SG143054A1/en unknown
- 2002-10-10 JP JP2002298010A patent/JP2003185668A/ja active Pending
-
2003
- 2003-09-09 HK HK03106390.0A patent/HK1054054A1/zh unknown
- 2003-11-12 US US10/706,542 patent/US20050026140A1/en not_active Abandoned
- 2003-11-12 US US10/706,547 patent/US20040096910A1/en not_active Abandoned
- 2003-11-12 US US10/706,543 patent/US20050032115A1/en not_active Abandoned
- 2003-11-12 US US10/706,544 patent/US20050026141A1/en not_active Abandoned
-
2004
- 2004-05-20 JP JP2004151015A patent/JP2004309493A/ja active Pending
- 2004-05-20 JP JP2004151016A patent/JP2004309494A/ja active Pending
- 2004-05-20 JP JP2004151017A patent/JP2004317520A/ja active Pending
- 2004-05-20 JP JP2004151018A patent/JP2004333503A/ja active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107121396A (zh) * | 2008-09-24 | 2017-09-01 | 曙光生命科学公司 | 用于检测分析物的方法 |
| CN107121396B (zh) * | 2008-09-24 | 2020-06-30 | 曙光生命科学公司 | 用于检测分析物的方法 |
| US8748122B2 (en) | 2008-12-16 | 2014-06-10 | BIO MéRIEUX, INC. | Methods for the characterization of microorganisms on solid or semi-solid media |
| US8795983B2 (en) | 2008-12-16 | 2014-08-05 | Biomerieux, Inc. | Methods for the characterization of microorganisms on solid or semi-solid media |
| CN102317777B (zh) * | 2008-12-16 | 2015-01-07 | 生物梅里埃有限公司 | 用于在固体或半固体介质上表征微生物的方法 |
| US9822389B2 (en) | 2008-12-16 | 2017-11-21 | bioMerièux, Inc | Method for the characterization of microorganisms on solid or semi-solid media |
| CN104697989A (zh) * | 2013-12-06 | 2015-06-10 | 中国科学院理化技术研究所 | 含Fe3+的复合黏土的制备及其变色法检测水体生物毒性的方法 |
| CN104697989B (zh) * | 2013-12-06 | 2017-08-25 | 中国科学院理化技术研究所 | 含Fe3+的复合黏土的制备及其变色法检测水体生物毒性的方法 |
| CN110087530A (zh) * | 2016-12-07 | 2019-08-02 | 普罗根尼蒂公司 | 胃肠道检测方法、装置和系统 |
| CN114359897A (zh) * | 2020-10-13 | 2022-04-15 | 深圳赛威玛智能科技有限公司 | 病原微生物的智能识别方法、计算机设备及可读存储介质 |
| CN117225491A (zh) * | 2023-11-15 | 2023-12-15 | 拜奥智能科技(山东)有限公司 | 一种可减少氨残留的定氮仪防溅瓶 |
| CN117225491B (zh) * | 2023-11-15 | 2024-01-16 | 拜奥智能科技(山东)有限公司 | 一种可减少氨残留的定氮仪防溅瓶 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20050026141A1 (en) | 2005-02-03 |
| US20050026140A1 (en) | 2005-02-03 |
| SG130937A1 (en) | 2007-04-26 |
| US20050032115A1 (en) | 2005-02-10 |
| JP2004309494A (ja) | 2004-11-04 |
| JP2003185668A (ja) | 2003-07-03 |
| SG143054A1 (en) | 2008-06-27 |
| SG152039A1 (en) | 2009-05-29 |
| US20040096910A1 (en) | 2004-05-20 |
| JP2004309493A (ja) | 2004-11-04 |
| SG145552A1 (en) | 2008-09-29 |
| SG152902A1 (en) | 2009-06-29 |
| CA2402588A1 (en) | 2003-05-01 |
| EP1308520A3 (en) | 2003-11-12 |
| EP1308520A2 (en) | 2003-05-07 |
| US20030124532A1 (en) | 2003-07-03 |
| JP2004317520A (ja) | 2004-11-11 |
| US6780602B2 (en) | 2004-08-24 |
| JP2004333503A (ja) | 2004-11-25 |
| HK1054054A1 (zh) | 2003-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1417347A (zh) | 分类学鉴定病源微生物及其毒性蛋白 | |
| Demarco et al. | Rapid detection of Escherichia coli O157: H7 in ground beef using a fiber-optic biosensor | |
| EP2255015B1 (en) | Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore sandwich assays | |
| Parro et al. | SOLID3: a multiplex antibody microarray-based optical sensor instrument for in situ life detection in planetary exploration | |
| US20060129327A1 (en) | Ultrasensitive sensor and rapid detection of analytes | |
| Parro et al. | Instrument development to search for biomarkers on Mars: terrestrial acidophile, iron-powered chemolithoautotrophic communities as model systems | |
| US20090061464A1 (en) | Methods for detecting and/or quantifying a concentration of specific bacterial molecules using bacterial biosensors | |
| Nesakumar et al. | Principles and recent advances in biosensors for pathogens detection | |
| Vishwakarma et al. | Aptamer-based approaches for the detection of waterborne pathogens | |
| Al-Awwal et al. | Nanoparticle immuno-fluorescent probes as a method for detection of viable E. coli O157: H7 | |
| Mason et al. | Taxonomic identification of microorganisms by capture and intrinsic fluorescence detection | |
| Suaifan et al. | Magnetic beads-based nanozyme for portable colorimetric biosensing of Helicobacter pylori | |
| US20060257929A1 (en) | Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins | |
| JPH02131598A (ja) | サルモネラ菌検査に用いるdnaプローブ及びそれを用いたサルモネラ菌の検出法 | |
| US7241626B2 (en) | Isolation and confirmation of analytes from test devices | |
| Xia et al. | A rapid detection of Escherichia coli O157: H7 by competition visual antigen macroarray | |
| EP0209554A1 (en) | Immunoassay systems for the detection of salmonella | |
| US9045516B2 (en) | Synthetic ligands for the differentiation of closely related toxins and pathogens | |
| Yaghoubi et al. | Detection of Shiga-like Toxin Produced by E. coli O157: H7 based on the LSPR Property of Gold Nanoparticles | |
| JP3607327B2 (ja) | 単一微生物細胞の迅速検出法 | |
| KR100376917B1 (ko) | 소화기 감염균들의 빠른 진단을 위한 프로브 및 이를이용한 dna 칩 및 검출 방법 | |
| Parro | Antibody microarrays for environmental monitoring | |
| AU9305698A (en) | Methods for the rapid detection of viable bacteria | |
| Suwannin | Smart Polymeric Nanoparticles-based Immunodiagnostic Platform and biosensor for Leptospira Detection | |
| Ramchandran et al. | Techniques for Detection, Quantification and Control of Bacterial Toxins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1054054 Country of ref document: HK |